April 19, 2022
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, N.E., Mail Stop 6628
Washington, D.C. 20549-6628
Commission File Number 000-49908
To Office of Chief Accountant:
We have received a copy of, and are in agreement with, the statements being made by CytoDyn Inc. in Item 4.01 of its Form 8-K dated April 19, 2022, captioned Changes in Registrants Certifying Accountant regarding our firm.
We hereby consent to the filing of this letter as an exhibit to the foregoing report on Form 8-K.
/s/ Warren Averett, LLC